1. Home
  2. VERA vs WEN Comparison

VERA vs WEN Comparison

Compare VERA & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$46.59

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$8.31

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
WEN
Founded
2016
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VERA
WEN
Price
$46.59
$8.31
Analyst Decision
Strong Buy
Hold
Analyst Count
11
21
Target Price
$76.60
$10.11
AVG Volume (30 Days)
1.1M
5.5M
Earning Date
02-25-2026
02-13-2026
Dividend Yield
N/A
6.73%
EPS Growth
N/A
0.63
EPS
N/A
0.95
Revenue
N/A
$2,208,190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.01
P/E Ratio
N/A
$8.80
Revenue Growth
N/A
N/A
52 Week Low
$18.53
$7.83
52 Week High
$56.05
$16.20

Technical Indicators

Market Signals
Indicator
VERA
WEN
Relative Strength Index (RSI) 50.00 47.85
Support Level $45.02 $8.30
Resistance Level $49.75 $8.70
Average True Range (ATR) 2.51 0.29
MACD -0.98 0.02
Stochastic Oscillator 18.54 35.38

Price Performance

Historical Comparison
VERA
WEN

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About WEN Wendy's Company (The)

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.

Share on Social Networks: